Live
ePaper
Search
Home > India > US FDA declines to approve Capricor's cell therapy for Duchenne muscular dystrophy

US FDA declines to approve Capricor's cell therapy for Duchenne muscular dystrophy

Written By:
Last Updated: November 21, 2026 05:06:47 IST

Nov 20 (Reuters) – The US Food and Drug Administration declined to approve Capricor Therapeutics' experimental cell therapy for a fatal inherited disease that weakens muscle, the health regulator said

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

MORE NEWS

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?